Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and Hypertension
Circulation Journal · 2025
DOI: 10.1253/circj.cj-24-0771 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, 2025. Verfasst von Ko Yamamoto und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kokura Memorial Hospital. Hauptthemen laut MEDLINE: Hypertension, Calcium Channel Blockers, Aortic Valve Stenosis, Registries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Research Institute for Production Development.
Abstract (Originalsprache)
BACKGROUND: There is a paucity of data on safety of calcium channel blockers (CCB) in patients with severe aortic stenosis (AS) and hypertension. METHODS AND RESULTS: Among 2,460 patients with severe AS and hypertension receiving antihypertensive therapy in the CURRENT AS registry-2, we compared the clinical outcomes between patients taking antihypertensive therapy with CCB (CCB group) and without CCB (no CCB group). In the entire study population, CCB was prescribed in 1,763 patients (71.7%), which was the most commonly prescribed antihypertensive agents. The prescription rates of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers, and thiazides were 61.9%, 25.6%, and 7.3% in the CCB group, and 75.8%, 54.4%, and 6.0% in the no CCB group. In the propensity score matched cohort, the cumulative 3-year incidence of all-cause death or hospitalization for heart failure was not different between the CCB and no CCB groups (38.3% vs. 38.7%, log-rank P=0.65; HR, 0.94; 95%CI, 0.77-1.15; P=0.56). The cumulative 3-year incidence of syncope was low regardless of CCB prescription (1.1% vs. 1.0%, P=0.74). CONCLUSIONS: Among patients with severe AS and hypertension, CCB was the most commonly prescribed antihypertensive agents, and antihypertensive therapy with CCB was associated with comparable clinical outcomes to antihypertensive therapy without CCB. Syncope was rarely seen in patients with severe AS and hypertension receiving antihypertensive therapy regardless of CCB prescription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Kokura Memorial Hospital.
- Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
- Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital.
- Department of Data Science, Hyogo Medical University.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.
- Division of Cardiovascular Surgery, Kokura Memorial Hospital.
Förderung
- Research Institute for Production Development
Zitieren
APA
Yamamoto, K., Takeji, Y., Taniguchi, T., Morimoto, T., Shirai, S., Kitai, T., Tabata, H., Ohno, N., Murai, R., Osakada, K., Murata, K., Nakai, M., Tsuneyoshi, H., Tada, T., Amano, M., Watanabe, S., Shiomi, H., Watanabe, H., Yoshikawa, Y., …, & CURRENT AS Registry-2 Investigators (2025). Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and Hypertension. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0771
Vancouver
Yamamoto K, Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, et al. Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and Hypertension. Circulation Journal. 2025. doi:10.1253/circj.cj-24-0771
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Ko and Takeji, Yasuaki and Taniguchi, Tomohiko and Morimoto, Takeshi and Shirai, Shinichi and Kitai, Takeshi and Tabata, Hiroyuki and Ohno, Nobuhisa and Murai, Ryosuke and Osakada, Kohei and Murata, Koichiro and Nakai, Masanao and Tsuneyoshi, Hiroshi and Tada, Tomohisa and Amano, Masashi and Watanabe, Shin and Shiomi, Hiroki and Watanabe, Hirotoshi and Yoshikawa, Yusuke and Nishikawa, Ryusuke and Obayashi, Yuki and Toyofuku, Mamoru and Tatsushima, Shojiro and Kanamori, Norio and Miyake, Makoto and Nakayama, Hiroyuki and Nagao, Kazuya and Izuhara, Masayasu and Nakatsuma, Kenji and Inoko, Moriaki and Fujita, Takanari and Kimura, Masahiro and Ishii, Mitsuru and Usami, Shunsuke and Nakazeki, Fumiko and Togi, Kiyonori and Inuzuka, Yasutaka and Ando, Kenji and Komiya, Tatsuhiko and Ono, Koh and Minatoya, Kenji and Kimura, Takeshi and CURRENT AS Registry-2 Investigators, CURRENT AS Registry-2 Investigators},
title = {Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and Hypertension},
journal = {Circulation Journal},
year = {2025},
doi = {10.1253/circj.cj-24-0771}
}
EUVIMED